AI Meets Aging: Inside The Longevity Revolution

Physiologically based pharmacokinetic (PBPK) modeling advancements are helping drug sponsors mitigate risk in preclinical and clinical studies through early identification of poor absorption properties.

Combining rigorous target validation, early toxicity and pharmacokinetic (PK) testing, and an iterative design process is crucial for identifying viable drug candidates early.

Explore two case studies where lung cancer therapies were delivered to the lung by dry powder inhaler in a rat model and evaluated for efficacy, confirming local delivery is a promising route.

Each excipient class helps stabilize biologics in different ways. Learn more about some of the most important excipients for biologics and how they provide stability to their formulation.

Discover how high-throughput, single-cell technologies combined with machine learning and automation are transforming clone selection to accelerate timelines and improve accuracy in bioprocessing.